BDTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Black Diamond Therapeutics Inc

Watchlist Manager

Watchlist

Price: 1.52 USD -5.59% Market Closed

Market Cap: $87.3m

Profitability Summary

Black Diamond Therapeutics Inc's profitability score is . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Sustainable 3Y Average Operating Margin

12%

Low Net Margin

Sustainable 3Y Average Net Margin

22%

Healthy Free Cash Flow Margin

Strong 3Y Average Free Cash Flow Margin

29%

Negative ROE

-37%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-185%

ROIC is Increasing

-303% > -289%

View All Checks

Profitability Score

Margins, capital efficiency and cash flow, summed up in one score.

Create a free account · No card needed

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.